Latest Interviews
Showing 1–3 of 3 transcripts.
Clear all filters- a16z8 min
The New Tech Stack for Virtual-First Care
The digital health sector is undergoing a transformative shift from isolated startup solutions to full-stack virtual clinics that leverage AI and modern technology to lower costs and improve care scale. While early growth was marked by redundant development of proprietary technology stacks, the market is now reaching a tipping point where demand supports dedicated infrastructure providers to abstract common clinical, administrative, and operational layers. Industry consolidation is anticipated as successful players evolve into risk-bearing, multi-stakeholder platforms that integrate digital and physical services to create network effects and eventually displace legacy fee-for-service models.
- a16z15 min
Healthcare: The Great Unlock
Accelerated by the pandemic, the healthcare sector is compressing a decade of transformation into two to three years through a fundamental shift from local, fee-for-service models to national, digital-first, value-based care. This dislocation is driven by labor reversals, insurance coverage changes, and regulatory mandates that favor remote care, forcing legacy providers to cede ground to startups owning the end-to-end patient journey. Consequently, a once-in-a-generation opportunity has emerged for startups to replace fragmented infrastructure with an automated, interoperable operating system that utilizes AI for intelligent supply-demand matching and dynamic insurance products.
- a16z18 min
Software Eats Care Delivery
A16Z BioFund partners identify the healthcare sector as a transformative growth opportunity comparable to the internet in 1999, driven by urgent needs for automation, data interoperability, and consumer-centric service models. The firm prioritizes investments in startups that streamline high-volume administrative tasks, unbundle acute care facilities, and leverage AI to enhance patient outcomes rather than replace clinical judgment. A16Z evaluates these opportunities by targeting companies with clear return on investment, recurring revenue streams, and distribution advantages that can overcome industry-wide inefficiencies and rising patient financial burdens.